NCT06991465View on ClinicalTrials.gov

Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA)

PHASE2RecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 16, 2023

Primary Completion Date

September 30, 2027

Study Completion Date

June 30, 2029

Conditions
Colorectal Carcinoma
Interventions
RADIATION

Radiation Therapy

High Dose Hypofractionated Radiotherapy 35 Gy over 5 fractions.

DRUG

FOLFOX regimen

Radiosensitizing chemotherapy

DRUG

Capecitabine

Radiosensitizing chemotherapy

Trial Locations (1)

H4A 3J1

RECRUITING

McGill University Health Centre, Montreal

All Listed Sponsors
collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

lead

Neil Kopek

OTHER